Abstract
ObjectiveThis study aimed to investigate the factors influencing weaning failure from invasive mechanical ventilation (IMV) in critically ill older patients with coronavirus disease 2019 (COVID-19). MethodsWe enrolled critically ill older patients with COVID-19 who were admitted to the medical intensive care unit (ICU) and received IMV between December 2022 and June 2023. ResultsWe included 68 critically ill older patients with COVID-19 (52 male [76.5 %] and 16 female individuals [23.5 %]). The patients’ median age (interquartile range) was 75.5 (70.3–82.8) years. The median length of ICU stay was 11.5 (7.0–17.8) days; 34 cases (50.0 %) were successfully weaned from IMV. The successfully weaned group had a higher proportion of underlying chronic obstructive pulmonary disease [6 (17.6 %) vs. 0, P = 0.033] and fewer cases of diabetes [7 (20.6 %) vs. 16 (47.1 %), P = 0.021] compared with the weaning failure group. Serum lactate levels [1.5 (1.2–2.3) vs. 2.6 (1.9–3.1) mmol/L, P < 0.001], blood urea nitrogen [8.2 (6.3–14.4) vs. 11.4 (8.0–21.3) mmol/L, P = 0.033], Acute Physiology and Chronic Health Evaluation (APACHE) II score [19.0 (12.0–23.3) vs. 22.5 (16.0–29.3), P = 0.014], and hospitalization days before endotracheal intubation [1.0 (0.0–5.0) vs. 3.0 (0.0–11.0), P = 0.023] were significantly decreased in the successfully weaned group, whereas PaO2/FiO2 [148.3 (94.6–200.3) vs. 101.1 (67.0–165.1), P = 0.038] and blood lymphocyte levels [0.6 (0.4–1.0) vs. 0.5 (0.2–0.6) 109/L, P = 0.048] were significantly increased, compared with the weaning failure group. Multivariate logistic regression analysis showed that diabetes (OR= 3.413, 95 %CI 1.029−11.326), P = 0.045), APACHE II Score (OR = 1.089, 95 % CI 1.008−1.175), P = 0.030), and hospitalization days before endotracheal intubation (OR = 1.137, 95 % CI 1.023−1.264), P = 0.017) were independent risk factors for weaning failure. ConclusionIn critically ill older patients with COVID-19 with diabetes, higher APACHE II Score, and longer hospitalization days before endotracheal intubation, weaning from IMV was more challenging. The study could help develop strategies for improving COVID-19 treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have